The size of the European enteral feeding devices market was worth USD 0.65 billion in 2023. It is estimated to grow at a CAGR of 5.24% and be worth USD 0.84 billion by 2028.
Enteral feeding devices are essential for people suffering from medical ailments such as swallowing disorders, digestive disorders, neurological disorders, cancer, and others.
The growing aging population suffering from chronic diseases majorly drives the European enteral feeding devices market growth. The prevalence of neurological disorders, stroke, and diabetes is significantly high among the European population, and the numbers are projected to rise in the foreseeable future. As per the World Economic Forum, an estimated 30% of the European population is expected to be aged 65 years by 2100. The growing incidence of chronic diseases can be attributed to the adoption of unhealthy diets, increased consumption of alcohol and tobacco, lack of physical activity, and other factors. Moreover, advancing age is often accompanied by progressive dementia disorder, leading to difficulties in swallowing, reduced nutritional intake, and changes in appetite functioning and apraxia. Therefore, enter feeding devices are becoming increasingly essential to aid in the recovery of these individuals.
The rising incidence of premature births in Europe further boosts the growth rate of the European enteral feeding devices market. In Europe, around 500,000 babies are born prematurely yearly, primarily due to maternal obesity and diabetes and other complications. These premature infants have low birth weights and underdeveloped internal organs, necessitating the use of enteral feeding devices to provide essential nutrients for optimal growth and development. These devices are typically inserted through the mouth or nose to ensure adequate nutrition for the infant's well-being and to prevent future complications.
The growing incidence of head and neck cancer in the European region accelerates the growth of the Europe enteral feeding devices market. Patients undergoing chemotherapy for head and neck cancer often experience malnutrition due to the treatment's adverse effects, such as loss of taste, fatigue, nausea and vomiting. In such cases, enteral tube feeding provides the necessary nutrients to aid in the patient's recovery and combat malnutrition. The use of enteral feeding devices has proven effective in supporting the health and well-being of patients suffering from this debilitating illness.
The growing adoption of advanced technologies in manufacturing supports regional market growth. Key market players in the region are placing a growing emphasis on developing portable enteral feeding devices, which is expected to drive market growth. Moreover, with the rising incidence of tube placement errors leading to complications such as lung injuries, manufacturers are introducing innovative products such as the DoubleCHEK device. This device assists clinicians and caregivers in the safe placement of nasogastric feeding tubes, highlighting the importance of technology in improving patient outcomes and driving market growth in Europe.
The high cost of advanced enteral feeding devices is a significant impediment to the European market growth, limiting their affordability and accessibility for patients. Moreover, usability issue, such as the potential for misplacement of feeding tubes, presents a challenge to the widespread adoption and uptake of these devices, thus hindering the market growth. Additionally, the need for improved infrastructure in hospitals, a shortage of skilled professionals and a lack of reimbursement policies in some countries inhibit the growth rate of the European enteral feeding devices market.
This research report on the European enteral feeding devices market has been segmented and sub-segmented into the following categories:
By Product Type:
Based on product type, the enteral feeding pump segment captured the major share of the European market in 2022 and the domination of the segment is anticipated to continue during the forecast period.
Based on stage, the pediatric segment is expected to play a leading role in the European market in the coming years.
Based on application, the oncology segment had the major share of the European market in 2022.
By End User:
Based on end-user, the hospital segment led the market in 2022. However, the ambulatory care services segment is expected to register the fastest CAGR in the coming years.
The European region accounted for a substantial share of the worldwide market in 2022 and is expected to witness a promising CAGR during the forecast period owing to the growing incidence of chronic and infectious diseases such as cancer and diabetes in the European region and the growing aging population, is creating a favorable market landscape. According to estimates, around 65% of elderly individuals in Europe suffer from at least one chronic disease, resulting in a significant demand for enteral nutrition. As a result, there has been a surge in demand for enteral feeding devices in the region, with an estimated 35% of European patients suffering from malnutrition. This trend is expected to continue, further driving market growth in the years ahead.
Europe is home to some of the renowned enteral food manufacturers such as Royal Numico NV, Novartis AG, Fresenius Kabi AG, Nestlé, and Abbott Laboratories Ltd. Among these, Abbott Laboratories Ltd holds the top position worldwide, owing to its strong presence in the United States. Novartis AG follows closely in second place. Notably, Abbott Laboratories Ltd, Novartis AG, and Royal Numico NV are located in Eastern Europe. Northern Europe, comprising Germany, the United Kingdom and the Netherlands, is a well-established market with high per capita consumption. Although these countries are not experiencing rapid development, it is crucial for companies to continue growing in stable markets. On the other hand, Southern Europe, comprising France, Spain and Italy, is a rapidly growing market with consistent growth over the past four to five years. Emerging markets in Eastern Europe are comparatively smaller but exhibit higher growth potential.
The UK market held the largest share of the European enteral feeding devices market in 2022. The usage of enteral tube feeding has been rising across the UK in recent years. With a particular emphasis on home enteral feeding to supplement nutrition for approximately 40,000 adult and pediatric patients in the United Kingdom alone, the UK market is estimated to register a healthy CAGR during the forecast period. To ensure efficient and effective feeding, the UK government has issued guidelines for approving feeding devices. These guidelines aim to provide patients with sufficient nutrition to promote a speedy recovery, thereby enhancing the overall quality of care.
The German enteral feeding devices market is expected to exhibit the highest CAGR among all the countries of Europe during the forecast period owing to the rising number of enteral feeding device manufacturers in Germany, which has facilitated the development of cost-effective enteral feeding devices. Additionally, the growing number of awareness programs regarding the usage of enteral feeding devices by German manufacturers are likely to boost the German market's growth further. Moreover, favorable reimbursement policies for enteral feeding device treatment are anticipated to promote the European market's growth rate. These policies are expected to incentivize healthcare providers to recommend enteral feeding devices, thereby driving demand for such devices in the region.
KEY MARKET PLAYERS:
Companies playing a notable role in the Europe enteral feeding devices market profiled in this report are Halyard Health Inc., C. R. Bard, Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
The Europe enteral feeding devices market size was valued at USD 0.62 bn in 2022.
The growing aging population, rising prevalence of chronic diseases, increasing demand for home-based enteral nutrition, and advancements in technology leading to more efficient and effective devices primarily boost the growth of the European market.
Abbott Laboratories, Fresenius Kabi AG, Danone Nutricia, Cardinal Health, Inc., and Nestle Health Science are some of the notable companies in the European enteral feeding devices market.
The outlook for this market is positive, with continued growth expected due to demographic trends, rising chronic disease prevalence, and ongoing advancements in technology.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com